| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 141, 335-342, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
CO Savage, BE Pottinger, G Gaskin, CD Pusey and JD Pearson
Section of Vascular Biology, Royal Postgraduate Medical School, London, United Kingdom.
The ability of vasculitis-associated anti-neutrophil cytoplasm antibodies (ANCA) to activate neutrophils and mediate release of radiolabel from 111Indium-labeled cultured human umbilical vein endothelial cells (HUVEC) was determined as a measure of the potential cytotoxicity of ANCA-activated neutrophils against vascular endothelium. Priming of neutrophils with low doses of phorbol 12- myristate 13-acetate (PMA) (1 ng/ml) and ionomycin (0.1 mumol/1) was required, together with pretreatment of endothelial cells with BCNU (1,3-bis-[2-chloroethyl]-1-nitrosourea; 0.26 mmol/l). Under these conditions and using a 4-hour serum-free assay system, mouse monoclonal antibodies (MAb) to the target autoantigens proteinase-3 (Pr-3) and myeloperoxidase (MPO) mediated enhanced release of 111Indium from HUVEC compared with control MAb. Human IgG Fab2 C-ANCA (recognizing Pr-3) and P-ANCA (recognizing MPO) did likewise. Preactivation of HUVEC with TNF (50 U/ml, 4 hr) enhanced the release of 111Indium from HUVEC generated by neutrophils activated with anti-Pr-3 and anti-MPO MAb. These data support the suggestion that activation of neutrophils by ANCA within the vascular lumen may contribute to endothelial cell injury.
This article has been cited by other articles:
 |
|
 |
|
  A. Uehara, Y. Hirabayashi, and H. Takada Antibodies to Proteinase 3 Prime Human Oral, Lung, and Kidney Epithelial Cells To Secrete Proinflammatory Cytokines upon Stimulation with Agonists to Various Toll-Like Receptors, NOD1, and NOD2 Clin. Vaccine Immunol., July 1, 2008; 15(7): 1060 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brachemi, A. Mambole, F. Fakhouri, L. Mouthon, L. Guillevin, P. Lesavre, and L. Halbwachs-Mecarelli Increased Membrane Expression of Proteinase 3 during Neutrophil Adhesion in the Presence of Anti Proteinase 3 Antibodies J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2330 - 2339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Xiao, A. Schreiber, P. Heeringa, R. J. Falk, and J. C. Jennette Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies Am. J. Pathol., January 1, 2007; 170(1): 52 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Huugen, J. W. Cohen Tervaert, and P. Heeringa TNF-{alpha} Bioactivity-Inhibiting Therapy in ANCA-Associated Vasculitis: Clinical and Experimental Considerations Clin. J. Am. Soc. Nephrol., September 1, 2006; 1(5): 1100 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-J. Ruth, A. R. Kitching, R. Y.Q. Kwan, D. Odobasic, J. D.K. Ooi, J. R. Timoshanko, M. J. Hickey, and S. R. Holdsworth Anti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1940 - 1949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Jennette, H. Xiao, and R. J. Falk Pathogenesis of Vascular Inflammation by Anti-Neutrophil Cytoplasmic Antibodies J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1235 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hattar, S. van Burck, A. Bickenbach, U. Grandel, U. Maus, J. Lohmeyer, E. Csernok, T. Hartung, W. Seeger, F. Grimminger, et al. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation J. Leukoc. Biol., October 1, 2005; 78(4): 992 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xiao, P. Heeringa, Z. Liu, D. Huugen, P. Hu, N. Maeda, R. J. Falk, and J. C. Jennette The Role of Neutrophils in the Induction of Glomerulonephritis by Anti-Myeloperoxidase Antibodies Am. J. Pathol., July 1, 2005; 167(1): 39 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schreiber, B. Otto, X. Ju, M. Zenke, U. Goebel, F. C. Luft, and R. Kettritz Membrane Proteinase 3 Expression in Patients with Wegener's Granulomatosis and in Human Hematopoietic Stem Cell-Derived Neutrophils J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2216 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. van Rossum, A. A. Rarok, M. G. Huitema, G. Fassina, P. C. Limburg, and C. G. M. Kallenberg Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies J. Leukoc. Biol., December 1, 2004; 76(6): 1162 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Rarok, P. C. Limburg, and C. G. M. Kallenberg Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies J. Leukoc. Biol., July 1, 2003; 74(1): 3 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schreiber, A. Busjahn, F. C. Luft, and R. Kettritz Membrane Expression of Proteinase 3 Is Genetically Determined J. Am. Soc. Nephrol., January 1, 2003; 14(1): 68 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Rarok, C. A. Stegeman, P. C. Limburg, and C. G. M. Kallenberg Neutrophil Membrane Expression of Proteinase 3 (PR3) Is Related to Relapse in PR3-ANCA-Associated Vasculitis J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2232 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kettritz, M. Choi, W. Butt, M. Rane, S. Rolle, F. C. Luft, and J. B. Klein Phosphatidylinositol 3-Kinase Controls Antineutrophil Cytoplasmic Antibodies--Induced Respiratory Burst in Human Neutrophils J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1740 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hattar, A. Bickenbach, E. Csernok, S. Rosseau, U. Grandel, W. Seeger, F. Grimminger, and U. Sibelius Wegener's granulomatosis: antiproteinase 3 antibodies induce monocyte cytokine and prostanoid release--role of autocrine cell activation J. Leukoc. Biol., June 1, 2002; 71(6): 996 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hattar, U. Grandel, A. Bickenbach, A. Schwarting, W.-J. Mayet, J. Bux, S. Jessen, C. Fischer, W. Seeger, F. Grimminger, et al. Interaction of Antibodies to Proteinase 3 (Classic Anti-Neutrophil Cytoplasmic Antibody) with Human Renal Tubular Epithelial Cells: Impact on Signaling Events and Inflammatory Mediator Generation J. Immunol., March 15, 2002; 168(6): 3057 - 3064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Harper, S. L. Nuttall, U. Martin, and C. O. S. Savage Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils Rheumatology, March 1, 2002; 41(3): 274 - 278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. PATRY, D. C. TREWICK, M. GREGOIRE, M. A. P. AUDRAIN, A. M. N. MOREAU, J.-Y. MULLER, K. MEFLAH, and V. L. M. ESNAULT Rats Injected with Syngenic Rat Apoptotic Neutrophils Develop Antineutrophil Cytoplasmic Antibodies J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1764 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Rooney, C. Taggart, R. Coakley, N. G. McElvaney, and S. J. O'Neill Anti-Proteinase 3 Antibody Activation of Neutrophils Can Be Inhibited by alpha 1-Antitrypsin Am. J. Respir. Cell Mol. Biol., June 1, 2001; 24(6): 747 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Hattar, U. Sibelius, A. Bickenbach, E. Csernok, W. Seeger, and F. Grimminger Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis J. Leukoc. Biol., January 1, 2001; 69(1): 89 - 97. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Raza, J. Thambyrajah, J. N. Townend, A. R. Exley, C. Hortas, A. Filer, D. M. Carruthers, and P. A. Bacon Suppression of Inflammation in Primary Systemic Vasculitis Restores Vascular Endothelial Function: Lessons for Atherosclerotic Disease? Circulation, September 26, 2000; 102(13): 1470 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I Schwarz and K. K Brown Rare diseases bullet 10: Small vessel vasculitis of the lung Thorax, June 1, 2000; 55(6): 502 - 510. [Full Text]
|
|
|
|
|
|
M. E. J. TAEKEMA-ROELVINK, C. VAN KOOTEN, E. HEEMSKERK, W. SCHROEIJERS, and M. R. DAHA Proteinase 3 Interacts with a 111-kD Membrane Molecule of Human Umbilical Vein Endothelial Cells J. Am. Soc. Nephrol., April 1, 2000; 11(4): 640 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. FOUCHER, P. HEERINGA, A. H. PETERSEN, M. G. HUITEMA, E. BROUWER, J. W. COHEN TERVAERT, J. PROP, P. CAMUS, J. J. WEENING, and C. G. M. KALLENBERG Antimyeloperoxidase-associated Lung Disease . An Experimental Model Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 987 - 994. [Abstract] [Full Text]
|
|
|
|
|
|
C. F. M. FRANSSEN, M. G. HUITEMA, A. C. M. KOBOLD, W. W. OOST-KORT, P. C. LIMBURG, A. TIEBOSCH, C. A. STEGEMAN, C. G. M. KALLENBERG, and J. W. C. TERVAERT In Vitro Neutrophil Activation by Antibodies to Proteinase 3 and Myeloperoxidase from Patients with Crescentic Glomerulonephritis J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1506 - 1515. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. C M. Kobold, C. G M Kallenberg, and J. W. C. Tervaert Monocyte activation in patients with Wegener's granulomatosis Ann Rheum Dis, April 1, 1999; 58(4): 237 - 245. [Abstract] [Full Text]
|
|
|
|
 |
|
 C G. Kallenberg and P Heeringa Pathogenesis of vasculitis Lupus, May 1, 1998; 7(4): 280 - 284. [Abstract] [PDF]
|
|
|
|
|
|
A. Burns Pulmonary vasculitis Thorax, March 1, 1998; 53(3): 220 - 227. [Full Text]
|
|
|
|
 |
|
 U. Sibelius, K. Hattar, A. Schenkel, T. Noll, E. Csernok, W. L. Gross, W.-J. Mayet, H.-M. Piper, W. Seeger, and F. Grimminger Wegener's Granulomatosis: Anti-proteinase 3 Antibodies Are Potent Inductors of Human Endothelial Cell Signaling and Leakage Response J. Exp. Med., February 16, 1998; 187(4): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M C Nash and M J Dillon Antineutrophil cytoplasm antibodies and vasculitis Arch. Dis. Child., September 1, 1997; 77(3): 261 - 264. [Full Text]
|
|
|
|
 |
|
 N. V. Rao, G. V. Rao, B. C. Marshall, and J. R. Hoidal Biosynthesis and Processing of Proteinase 3 in U937 Cells J. Biol. Chem., February 9, 1996; 271(6): 2972 - 2978. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
